Life is precious takeaway from terror attack in Nice
Westlake Village financial planner John C. Lindsey had just arrived in Nice for a family vacation when his ordeal began. After an “awesome Bastille Day fireworks show,” the July 14 terror attack started with a crowd running toward him and his son-in-law as he enjoyed a celebratory cigar. They immediately “ducked back into their hotel,” Read More →
Read More →Soft skills key to successful managers
By Vlad Vaiman Executives often promote outstanding employees to supervisory or managerial positions as part of their strategy to retain the best ones. There is nothing wrong with promoting the best people to management ranks, but the problem is that most of them lack managerial skills. A promotion can start out well but turn into Read More →
Read More →Amgen settles lawsuit, says biosimilar works as well as Herceptin
Amgen settled a lawsuit and released positive news about a breast cancer biosimilar this week. The Thousand Oaks-based biotech giant said July 20 the company reached a settlement stemming from a class action lawsuit involving shareholders who sued the company over shares bought from the company between April 22, 2004 and May 10, 2007. Amgen Read More →
Read More →Santa Barbara’s Pensionmark adds affiliate in New York
Santa Barbara-based Pensionmark Retirement Group added an affiliate office in New York. Pensionmark is a financial retirement planning and executive compensation consulting firm. The New York-based Ridge Retirement Consultants and its team of four advisers will join the Pensionmark’s Adviser Support Program. Ridge Retirement has nearly 50 corporate clients and $1.7 billion in assets under Read More →
Read More →Citizens Business Bank second quarter net income down from 2015
CVB Financial Corp. and its subsidiary Citizens Business Bank reported $25.5 million net income for the second quarter of 2016, or 23 cents per share. That was down from $26.8 million for the second quarter of 2015, or 25 cents per share. Citizens Business Bank completed the integration of County Commerce Bank in the second Read More →
Read More →FDA declines to approve Novartis biosimilar for Amgen’s Neulasta
The Food and Drug Administration has declined for now to approve a copycat version of Amgen’s blockbuster drug Neulasta. Reuters reported July 19 that the FDA sent a letter to Swiss pharmaceutical Novartis at the end of June saying it was declining to approve the drug for now. Neulasta, made by Thousand Oaks-based biotech giant Read More →
Read More →Lockheed Martin second quarter earnings beat analyst estimates
Lockheed Martin revenues increased slightly and the company beat analyst estimates when it reported second quarter earnings results July 19. Lockheed Martin said sales increased during the quarter from $11.6 billion during the same quarter in 2015 to $12.9 billion in 2016. Earnings per share increased from $2.94 to $3.32 per share over the same Read More →
Read More →
Sponsored content:
2015-2016 Giving Guide
